Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis
Last Updated: Friday, March 24, 2023
A systematic review of PubMed, Embase and Web of Science and meta-analysis showed that zoledronic acid is associated with a decreased incidence of skeletal-related events (SREs), increased time to first on-study SRE, and reduction in pain level in the management of bone metastases among patients with cancer, compared with placebo.
Advertisement
News & Literature Highlights